PharmalLive Releases from Pipeline to Market 2007, an ExclusiveAnnual Special Report
NEWTOWN, Pa, June 21, 2007 – Published annually, the From Pipeline to Market Special Report details information about prescription drugs in development and on the market in the United States, including new chemical entities, indications, and formulations. The Special Report is designed to expand upon editorial features found in Med Ad News and R&D Directions.
From Pipeline to Market 2007, available in PDF format, separates drugs into sections by their approved or development status. Each section provides such details as the product’s commercial name or product code, chemical or substance composition, the approved or intended application, and developer with company Website.
For more information, contact Keith Guinn at 215-867-0044, ext. 223, or email@example.com.
Providing access to breaking news, industry-leading publications, informative eNewsletters, data-rich interactive products, and other Engel Publishing Partners products, PharmaLive.com is the industry’s premier source for up-to-the-minute pharmaceutical and biotechnology news with more than 150,000 unique visitors per month.
About Engel Publishing Partners
For 25 years, Engel Publishing Partners has been the source that pharmaceutical executives turn to for the information they need to create competitive business strategies. Engel Publishing Partners carries a full product line offering industry-leading publications including Med Ad News and R&D Directions, informative newsletters, and data-rich interactive products. Through these channels, Engel disseminates original and un-biased content that provides insight into industry trends and events, as well as extensive analysis of companies, products, and pipelines.
Posted: June 2007